Peripheral Vascular Devices | Market Insights | Japan | 2023
Growing adoption of premium-priced DES and DCBs will be fueled by the continued emergence of data supporting the safety of paclitaxel-coated devices, resulting in modest growth in the Japanese PV device market. The impact of the COVID-19 pandemic in the short term, as well as ASP declines caused by MHLW biennial reimbursement cuts over the forecast period, will limit market revenues.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Japan from 2019 through 2031.